African countries are holding the 13th International AIDS Society (IAS) conference on HIV in Kigali, Rwanda.
The conference aims at getting support in dealing with the scourge from the continent's development partners.
Kenya is emerging as a key player in piloting next-generation prevention tools-chief among them, lenacapavir.
On July 14, 2025 at the IAS, the World Health Organisation (WHO) approved a new HIV prevention drug called lenacapavir. It's an injection given just twice a year and helps protect people from getting HIV.
